Aquaporin 1 and pulmonary hypertension
水通道蛋白 1 和肺动脉高压
基本信息
- 批准号:10538750
- 负责人:
- 金额:$ 70.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-12-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AQP1 geneApoptosisApoptoticBindingBinding SitesBlood VesselsBlood capillariesC-terminalCell AdhesionCell HypoxiaCell NucleusCell ProliferationCell SurvivalCell physiologyCellsComplexDataDevelopmentDiseaseDistalEndothelial CellsEndotheliumEpithelial CellsFailureFamily memberHumanHypoxiaKnowledgeLaboratoriesLesionLungMediatingModelingMolecularMuscleMutateNuclearNuclear TranslocationPathologyPathway interactionsPatientsPermeabilityPhenotypePredispositionPreventionProtein FamilyProteinsPublishingPulmonary HypertensionPulmonary arterial remodelingRattusRegulationReportingRepressionResistanceRoleSignal PathwaySignal TransductionSmooth MuscleSmooth Muscle MyocytesStimulusTailTestingUp-RegulationVascular remodelingWaterbasebeta catenincell growthcell motilitycytochrome cexperimental studyglycogen synthase kinase 3 betaimprovedin silicoinsightlung microvascular endothelial cellsmigrationmortalitynovelnovel therapeuticspreventprotein functionprotein protein interactionpulmonary arterial hypertensionpulmonary arterial pressurerenal epitheliumresponseright ventricular failuretherapeutic targetwater channel
项目摘要
PROJECT SUMMARY
Pulmonary arterial hypertension (PAH) is a severely debilitating disease with no cure. Morphometric
studies revealed that the development of pulmonary hypertension is associated with robust structural
remodeling of the small pulmonary arteries, characterized by thickening of the endothelial and smooth muscle
cell layers and formation of occlusive lesions. In addition to increased proliferation and migration of vascular
cells, failure of appropriate apoptosis (i.e., apoptotic resistance) contributes to remodeling via lack of cell
turnover. Our laboratory identified a new candidate as a regulator of pulmonary arterial smooth muscle cell
(PASMC) function: aquaporins (AQPs). AQPs are a family of proteins that form transmembrane channels
which facilitate the transport of water into and out of cells. We have evidence that aquaporin 1 (AQP1), the first
family member identified, is expressed in PASMCs and pulmonary microvascular endothelial cells (PMVECs),
upregulated in a rat model of PAH and modulates susceptibility to apoptosis. Our preliminary data also indicate
that increased AQP1 protein is associated with elevated β-catenin expression, a protein that regulates
migratory, proliferative and survival responses. The mechanism by which AQP1 regulates β-catenin levels is
currently unknown; we have generated exciting data indicating a critical role for a specific region of the AQP1
C-terminal tail. This region contains a previously unrecognized putative binding site for GSK3β, an endogenous
regulator of β-catenin abundance. Based on these data, we hypothesize that in PAH PASMCs and PMVECs,
increased AQP1 levels contribute to cell growth and survival by sequestering GSK3β and reducing its
activity/nuclear localization; as a consequence, β-catenin accumulates, promoting migration and proliferation
and preventing apoptosis. The Aims of this study are to: 1) determine whether AQP1 regulates β-catenin via
binding to GSK3β; 2) identify the mechanism by which AQP1 facilitates cell growth and survival; and 3)
evaluate whether cell-specific disruption of AQP1 prevents or reverses PAH.
项目总结
肺动脉高压(PAH)是一种无法治愈的严重衰弱疾病。形态测量学
研究表明,肺动脉高压的发展与强健的结构有关。
肺小动脉重塑,特征是内皮细胞和平滑肌增厚
细胞层和闭塞病变的形成。除了增加血管的增殖和迁移
细胞,适当的凋亡失败(即,抗凋亡)通过缺乏细胞而导致重塑
营业额。我们的实验室确定了一种新的候选细胞作为肺动脉平滑肌细胞的调节剂。
PASMC功能:水通道蛋白(AQPs)。水通道蛋白是一类形成跨膜通道的蛋白质。
这有助于水进出细胞的运输。我们有证据表明水通道蛋白1(AQP1),第一个
已鉴定的家族成员,表达于PASMC和肺微血管内皮细胞(PMVECs),
在PAH大鼠模型中上调,并调节对细胞凋亡的敏感性。我们的初步数据还表明
水通道蛋白1蛋白的增加与β-连环蛋白表达的增加有关,这是一种调节
迁移、增殖和存活反应。水通道蛋白1调节β-连环蛋白水平的机制是
目前尚不清楚;我们已经生成了令人兴奋的数据,表明AQP1的特定区域具有关键作用
C-末端尾巴。该区域包含一个先前未知的与Gsk3β的推测结合位点,Gsk3是一种内源性
β-连环蛋白丰度的调节。基于这些数据,我们假设在PAH PASMC和PMVEC中,
水通道蛋白1水平的增加通过隔离GSK3β并减少其
活性/核定位;结果,β-连环蛋白积聚,促进迁移和扩散
和防止细胞凋亡。本研究的目的是:1)确定水通道蛋白1是否通过调节β-连环蛋白
结合Gsk3β;2)确定水通道蛋白1促进细胞生长和存活的机制;3)
评估AQP1的细胞特异性干扰是否可以预防或逆转PAH。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Larissa A. Shimoda其他文献
Larissa A. Shimoda的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Larissa A. Shimoda', 18)}}的其他基金
Functional linkage of NHE1 and calpain in IPAH
IPAH 中 NHE1 和钙蛋白酶的功能联系
- 批准号:
8354085 - 财政年份:2012
- 资助金额:
$ 70.46万 - 项目类别:
Functional linkage of NHE1 and calpain in IPAH
IPAH 中 NHE1 和钙蛋白酶的功能联系
- 批准号:
8526547 - 财政年份:2012
- 资助金额:
$ 70.46万 - 项目类别:
Interrogation of the Cellular Pathogenesis of Pulmonary Hypertension
肺动脉高压的细胞发病机制的探讨
- 批准号:
8197835 - 财政年份:2011
- 资助金额:
$ 70.46万 - 项目类别:
Chronic hypoxia and pulmonary vascular smooth muscle
慢性缺氧与肺血管平滑肌
- 批准号:
6789297 - 财政年份:2003
- 资助金额:
$ 70.46万 - 项目类别:
Chronic hypoxia and pulmonary vascular smooth muscle
慢性缺氧与肺血管平滑肌
- 批准号:
6915721 - 财政年份:2003
- 资助金额:
$ 70.46万 - 项目类别:
Chronic hypoxia and pulmonary vascular smooth muscle
慢性缺氧与肺血管平滑肌
- 批准号:
7093559 - 财政年份:2003
- 资助金额:
$ 70.46万 - 项目类别:
Chronic Hypoxia and pH Homeostasis in Pulmonary Myocytes
肺肌细胞的慢性缺氧和 pH 稳态
- 批准号:
8287004 - 财政年份:2003
- 资助金额:
$ 70.46万 - 项目类别:
Chronic Hypoxia and pH Homeostasis in Pulmonary Myocytes
肺肌细胞的慢性缺氧和 pH 稳态
- 批准号:
8505017 - 财政年份:2003
- 资助金额:
$ 70.46万 - 项目类别:
Chronic hypoxia and pH homeostasis in pulmonary myocytes
肺肌细胞的慢性缺氧和 pH 稳态
- 批准号:
7076849 - 财政年份:2003
- 资助金额:
$ 70.46万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
- 批准号:
10596657 - 财政年份:2021
- 资助金额:
$ 70.46万 - 项目类别:
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
- 批准号:
10417219 - 财政年份:2021
- 资助金额:
$ 70.46万 - 项目类别:
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2015
- 资助金额:
$ 70.46万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2014
- 资助金额:
$ 70.46万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Understanding the activation of pro-apoptotic Bcl-2 family proteins for the development of modulators of apoptosis
了解促凋亡 Bcl-2 家族蛋白的激活以开发凋亡调节剂
- 批准号:
nhmrc : 1059331 - 财政年份:2014
- 资助金额:
$ 70.46万 - 项目类别:
Project Grants
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2013
- 资助金额:
$ 70.46万 - 项目类别:
Postgraduate Scholarships - Doctoral
Apoptotic Osteocytes Promote Chondrocyte Apoptosis via Soluble Factors
凋亡骨细胞通过可溶性因子促进软骨细胞凋亡
- 批准号:
251802 - 财政年份:2012
- 资助金额:
$ 70.46万 - 项目类别:
Studentship Programs
Defining the mechanism(s) by which the cellular inhibitor of apoptosis protein 2 (cIAP2) contributes to early stage atherosclerosis development by directly promoting the participation of key apoptotic pathways within lesion-associated macrophages
确定凋亡蛋白细胞抑制剂 2 (cIAP2) 通过直接促进病变相关巨噬细胞内关键凋亡途径的参与来促进早期动脉粥样硬化发展的机制
- 批准号:
191299 - 财政年份:2009
- 资助金额:
$ 70.46万 - 项目类别:
Operating Grants
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
- 批准号:
8075522 - 财政年份:2009
- 资助金额:
$ 70.46万 - 项目类别:
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
- 批准号:
7676912 - 财政年份:2009
- 资助金额:
$ 70.46万 - 项目类别:














{{item.name}}会员




